301281 科源制药
已收盘 08-14 15:00:00
资讯
新帖
简况
科源制药（301281）披露控股股东部分股份解除质押及再质押公告，8月13日股价下跌3.31%
证券之星 · 08-13 22:39
科源制药（301281）披露控股股东部分股份解除质押及再质押公告，8月13日股价下跌3.31%
科源制药（301281）股东力诺投资控股集团有限公司质押205万股，占总股本1.89%
证券之星 · 08-13 18:22
科源制药（301281）股东力诺投资控股集团有限公司质押205万股，占总股本1.89%
股市必读：科源制药新发布《关于全资子公司收到药品补充申请批准通知书暨参与国家药品集中采购拟中选的公告》
证券之星 · 08-04
股市必读：科源制药新发布《关于全资子公司收到药品补充申请批准通知书暨参与国家药品集中采购拟中选的公告》
科源制药：子公司两款产品入选国家药品集中采购
美股速递 · 08-03
科源制药：子公司两款产品入选国家药品集中采购
科源制药(301281.SZ)：两款产品拟中选国家药品集中采购
智通财经 · 08-03
科源制药(301281.SZ)：两款产品拟中选国家药品集中采购
股市必读：科源制药（301281）7月30日董秘有最新回复
证券之星 · 07-31
股市必读：科源制药（301281）7月30日董秘有最新回复
科源制药：公司员工规模及人均创收的变动，主要受公司经营战略调整与业务结构优化的综合影响
证券之星 · 07-30
科源制药：公司员工规模及人均创收的变动，主要受公司经营战略调整与业务结构优化的综合影响
科源制药（301281）披露关于开设募集资金专户并签订三方监管协议的公告，7月22日股价下跌3.98%
证券之星 · 07-22
科源制药（301281）披露关于开设募集资金专户并签订三方监管协议的公告，7月22日股价下跌3.98%
股市必读：科源制药（301281）预计2026年1-6月扣非后净利润盈利5200万元至5700万元
证券之星 · 07-21
股市必读：科源制药（301281）预计2026年1-6月扣非后净利润盈利5200万元至5700万元
科源制药（301281）披露2026年半年度业绩预告，7月20日股价下跌5.07%
证券之星 · 07-20
科源制药（301281）披露2026年半年度业绩预告，7月20日股价下跌5.07%
科源制药：预计2026年1-6月归属净利润盈利6000万元至6500万元
证券之星 · 07-20
科源制药：预计2026年1-6月归属净利润盈利6000万元至6500万元
科源制药(301281.SZ)发预增，预计上半年归母净利润6000万元-6500万元，同比增长40.57%-52.29%
智通财经 · 07-20
科源制药(301281.SZ)发预增，预计上半年归母净利润6000万元-6500万元，同比增长40.57%-52.29%
科源制药（301281）披露控股股东部分股份解除质押及再质押公告，7月17日股价下跌17.48%
证券之星 · 07-17
科源制药（301281）披露控股股东部分股份解除质押及再质押公告，7月17日股价下跌17.48%
科源制药（301281）披露股东股份减持计划预披露公告，7月16日股价下跌5.14%
证券之星 · 07-16
科源制药（301281）披露股东股份减持计划预披露公告，7月16日股价下跌5.14%
7月15日增减持汇总：中创智领披露增持情况，科源制药等5股拟减持（表）
新浪证券 · 07-15
7月15日增减持汇总：中创智领披露增持情况，科源制药等5股拟减持（表）
科源制药股东拟减持不超过3%股份
投资观察 · 07-15
科源制药股东拟减持不超过3%股份
科源制药：股东拟合计减持不超3.57%公司股份
格隆汇 · 07-15
科源制药：股东拟合计减持不超3.57%公司股份
科源制药最新公告：股东拟合计减持不超3.57%股份
证券之星 · 07-15
科源制药最新公告：股东拟合计减持不超3.57%股份
7月2日科源制药（301281）龙虎榜数据：机构净卖出701.05万元（3日）
证券之星 · 07-02
7月2日科源制药（301281）龙虎榜数据：机构净卖出701.05万元（3日）
科源制药（301281）披露全资子公司银行账户解除冻结公告，6月24日股价下跌2.7%
证券之星 · 06-24
科源制药（301281）披露全资子公司银行账户解除冻结公告，6月24日股价下跌2.7%
加载更多
公司概况
公司名称：
山东科源制药股份有限公司
所属行业：
医药制造业
上市日期：
2023-04-04
主营业务：
山东科源制药股份有限公司的主营业务是化学原料药及其制剂产品的研发、生产和销售。公司的主要产品是格列齐特、盐酸二甲双胍、盐酸罗哌卡因、单硝酸异山梨酯、单硝酸异山梨酯片、单硝酸异山梨酯缓释片、盐酸氟西汀分散片、化工中间体产品。
发行价格：
44.18
{"stockData":{"symbol":"301281","market":"SZ","secType":"STK","nameCN":"科源制药","latestPrice":43.65,"timestamp":1786691019000,"preClose":44.66,"halted":0,"volume":2741800,"delay":0,"changeRate":-0.0226,"floatShares":70952000,"shares":108000000,"eps":0.2174,"marketStatus":"已收盘","change":-1.01,"latestTime":"08-14 15:00:00","open":44.4,"high":44.85,"low":42.78,"amount":119000000,"amplitude":0.0464,"askPrice":43.65,"askSize":52,"bidPrice":43.61,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.2174,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":44.66,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":49.13,"lowLimit":40.19,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108290000,"isCdr":false,"pbRate":3.47,"roa":"--","peRate":200.781969,"roe":"2.19%","epsLYR":0.15,"committee":-0.351499,"marketValue":4727000000,"turnoverRate":0.0386,"status":1,"floatMarketCap":3097000000},"requestUrl":"/m/hq/s/301281","defaultTab":"news","newsList":[{"id":"2659631271","title":"科源制药（301281）披露控股股东部分股份解除质押及再质押公告，8月13日股价下跌3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659631271","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659631271?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:39","pubTimestamp":1786631953,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，科源制药报收于44.66元，较前一交易日下跌3.31%，最新总市值为48.36亿元。公司于2026年8月13日披露《关于控股股东部分股份解除质押及再质押的公告》。本次解除质押及再质押后，力诺投资累计质押股份仍为29,340,000股，占其所持股份比例74.62%，占公司总股本比例27.09%。质押股份均为首发前限售股，不存在业绩补偿义务，未对上市公司生产经营造成实质影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300039993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659531631","title":"科源制药（301281）股东力诺投资控股集团有限公司质押205万股，占总股本1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659531631","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659531631?lang=zh_cn&edition=full","pubTime":"2026-08-13 18:22","pubTimestamp":1786616554,"startTime":"0","endTime":"0","summary":"证券之星消息，科源制药8月13日公开信息显示，股东力诺投资控股集团有限公司向中国邮政储蓄银行股份有限公司济南市历城区支行合计质押205.0万股，占总股本1.89%。质押详情见下表：截止本公告日，股东力诺投资控股集团有限公司已累计质押股份2934.0万股，占其持股总数的74.62%。科源制药主营业务：化学原料药及其制剂产品的研发、生产和销售。本文数据来源于科源制药公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300032277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656830533","title":"股市必读：科源制药新发布《关于全资子公司收到药品补充申请批准通知书暨参与国家药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656830533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656830533?lang=zh_cn&edition=full","pubTime":"2026-08-04 01:20","pubTimestamp":1785777624,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，科源制药报收于35.45元，上涨5.04%，换手率5.2%，成交量3.69万手，成交额1.27亿元。公司公告汇总：全资子公司力诺制药获盐酸倍他司汀片上市许可持有人变更批准，并参与第12批国家药品集采，注射用硫酸艾沙康唑拟中选，采购周期至2029年12月31日。交易信息汇总资金流向8月3日主力资金净流入550.75万元，占总成交额4.33%；游资资金净流入709.37万元，占总成交额5.58%；散户资金净流出1260.11万元，占总成交额9.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103258411","title":"科源制药：子公司两款产品入选国家药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=1103258411","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103258411?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:09","pubTimestamp":1785730170,"startTime":"0","endTime":"0","summary":"科源制药（Shandong Keyuan Pharmaceutical Co., Ltd.）近日宣布，其子公司旗下两款产品已被正式纳入国家药品集中采购名单之中。这一消息标志着企业在药品市场准入领域取得了关键性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656156347","title":"科源制药(301281.SZ)：两款产品拟中选国家药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656156347","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656156347?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:02","pubTimestamp":1785729735,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 科源制药(301281.SZ)发布公告，近日，子公司力诺制药参加了第12批国家组织药品集中带量采购的投标。根据国家组织药品联合采购办公室(以下简称“联合采购办公室”)发布的《第12批国家组织药品集中带量采购拟中选结果公示》，力诺制药产品拟中选本次集中采购。拟中选产品为：注射用硫酸艾沙康唑、盐酸倍他司汀片。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655296807","title":"股市必读：科源制药（301281）7月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655296807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655296807?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:03","pubTimestamp":1785434599,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，科源制药报收于31.04元，下跌4.64%，换手率4.92%，成交量3.49万手，成交额1.11亿元。董秘最新回复投资者： 董秘您好！当日关注点交易信息汇总：7月30日主力资金净流入315.14万元，占总成交额2.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655841764","title":"科源制药：公司员工规模及人均创收的变动，主要受公司经营战略调整与业务结构优化的综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2655841764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655841764?lang=zh_cn&edition=full","pubTime":"2026-07-30 11:33","pubTimestamp":1785382389,"startTime":"0","endTime":"0","summary":"证券之星消息，科源制药07月30日在投资者关系平台上答复投资者关心的问题。翻阅近年公司年报发现，公司员工同比缩减 6.61%、人均创收下降 8.05%，两项指标同步承压，想咨询背后主导因素？感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000014658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653766291","title":"科源制药（301281）披露关于开设募集资金专户并签订三方监管协议的公告，7月22日股价下跌3.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653766291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653766291?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:41","pubTimestamp":1784731276,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，科源制药报收于35.0元，较前一交易日下跌3.98%，最新总市值为37.9亿元。科源制药于2026年7月22日披露《关于开设募集资金专户并签订三方监管协议的公告》。公告显示，公司于2026年5月29日召开第四届董事会第二十三次会议，审议通过《关于变更部分募集资金专户的议案》。公司已与上述银行及保荐机构中信建投证券签订《募集资金三方监管协议》，协议内容符合监管要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653121088","title":"股市必读：科源制药（301281）预计2026年1-6月扣非后净利润盈利5200万元至5700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653121088","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653121088?lang=zh_cn&edition=full","pubTime":"2026-07-21 00:59","pubTimestamp":1784566749,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，科源制药报收于37.6元，下跌5.07%，换手率7.46%，成交量5.3万手，成交额2.03亿元。业绩披露要点业绩预告科源制药预计2026年1-6月归属净利润盈利6000万元至6500万元；扣非后净利润盈利5200万元至5700万元。公司公告汇总2026年半年度业绩预告山东科源制药股份有限公司预计2026年1月1日至6月30日归属于上市公司股东的净利润为6,000万元至6,500万元，较上年同期增长40.57%-52.29%；扣除非经常性损益后的净利润为5,200万元至5,700万元，同比增长44.97%-58.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100001049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652211937","title":"科源制药（301281）披露2026年半年度业绩预告，7月20日股价下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652211937?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:21","pubTimestamp":1784557281,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，科源制药报收于37.6元，较前一交易日下跌5.07%，最新总市值为40.72亿元。该股当日开盘40.79元，最高41.01元，最低36.36元，成交额达2.03亿元，换手率为7.46%。公司于2026年7月20日披露《2026年半年度业绩预告》，预计2026年1月1日至6月30日归属于上市公司股东的净利润为6,000万元至6,500万元，较上年同期增长40.57%-52.29%；扣除非经常性损益后的净利润为5,200万元至5,700万元，同比增长44.97%-58.91%。预告数据未经审计，最终以半年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652299986","title":"科源制药：预计2026年1-6月归属净利润盈利6000万元至6500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652299986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652299986?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:56","pubTimestamp":1784537779,"startTime":"0","endTime":"0","summary":"证券之星消息，科源制药发布业绩预告，预计2026年1-6月归属净利润盈利6000万元至6500万元。科源制药2026年一季报显示，一季度公司主营收入1.61亿元，同比上升45.05%；归母净利润3007.34万元，同比上升30.27%；扣非净利润2842.69万元，同比上升50.17%；负债率22.19%，投资收益60.0万元，财务费用19.02万元，毛利率57.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000025357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652968192","title":"科源制药(301281.SZ)发预增，预计上半年归母净利润6000万元-6500万元，同比增长40.57%-52.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652968192","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652968192?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:29","pubTimestamp":1784536162,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科源制药(301281.SZ)发布2026年半年度业绩预告，预计上半年归属于上市公司股东的净利润6000万元-6500万元，同比增长40.57%-52.29%。公司加大制剂市场的开发力度，积极引入新产品，新产品销售额增加，同时公司持续优化内部精细化运营管理，稳步推进降本增效相关工作，生产效率提高，使制剂产品毛利有所增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科源制药(301281.SZ)发预增，预计上半年归母净利润6000万元-6500万元，同比增长40.57%-52.29%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652033401","title":"科源制药（301281）披露控股股东部分股份解除质押及再质押公告，7月17日股价下跌17.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652033401","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652033401?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:45","pubTimestamp":1784281517,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，科源制药报收于39.61元，较前一交易日下跌17.48%，最新总市值为42.89亿元。该股当日开盘48.5元，最高48.5元，最低39.51元，成交额达2.42亿元，换手率为7.99%。近日，科源制药披露《关于控股股东部分股份解除质押及再质押的公告》。本次质押股份占其所持股份比例11.44%，占公司总股本比例4.16%，均为首发前限售股。截至公告日，力诺投资累计质押股份29,340,000股，占其所持股份74.62%，占公司总股本27.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700032667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410428","title":"科源制药（301281）披露股东股份减持计划预披露公告，7月16日股价下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410428","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651410428?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:21","pubTimestamp":1784193671,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，科源制药报收于48.0元，较前一交易日下跌5.14%，最新总市值为51.98亿元。该股当日开盘49.26元，最高52.3元，最低47.1元，成交额达2.92亿元，换手率为8.36%。近日，科源制药发布《关于股东股份减持计划的预披露公告》。减持期间为公告披露之日起十五个交易日后三个月内，价格根据二级市场价格确定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651469874","title":"7月15日增减持汇总：中创智领披露增持情况，科源制药等5股拟减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2651469874","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651469874?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:42","pubTimestamp":1784122920,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据不完全统计，7月15日盘后，中创智领披露增持情况，科源制药、獐子岛、中洲特材、海星股份、京能热力5家A股公司披露拟减持情况。\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：宋雅芳","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-07-15/doc-inihxaew4680655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["601717","BK0188","BK0264","BK0028","BK0239","301281","BK1171","00564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102916689","title":"科源制药股东拟减持不超过3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1102916689","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102916689?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:24","pubTimestamp":1784114681,"startTime":"0","endTime":"0","summary":"科源制药（301281.SZ）于7月15日发布公告称，公司一名股东计划减持其持有的公司股份，减持比例最高可达公司总股本的3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651245764","title":"科源制药：股东拟合计减持不超3.57%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651245764","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651245764?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:15","pubTimestamp":1784114140,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457885","title":"科源制药最新公告：股东拟合计减持不超3.57%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651457885?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:00","pubTimestamp":1784113251,"startTime":"0","endTime":"0","summary":"科源制药(301281.SZ)公告称，股东济南安富创业投资合伙企业(有限合伙)计划减持不超过61.29万股(占公司总股本0.57%)，股东问泽鸿计划减持不超过324.87万股(占公司总股本3.00%)，合计减持不超过公司总股本的3.57%。减持原因为自身经营及资金需要，减持方式为集中竞价和大宗交易。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500037883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648950504","title":"7月2日科源制药（301281）龙虎榜数据：机构净卖出701.05万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2648950504","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648950504?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:42","pubTimestamp":1782985347,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月2日公布的交易公开信息显示，科源制药因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月2日收盘，科源制药报收于58.05元，上涨3.13%，换手率10.34%，成交量7.33万手，成交额4.23亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出701.05万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200029812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645058899","title":"科源制药（301281）披露全资子公司银行账户解除冻结公告，6月24日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645058899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645058899?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:47","pubTimestamp":1782294445,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，科源制药报收于47.14元，较前一交易日下跌2.7%，最新总市值为51.05亿元。近日，科源制药发布《关于全资子公司银行账户解除冻结的公告》。公告显示，公司全资子公司山东力诺制药有限公司因与江苏赛邦药业有限公司合同纠纷，部分银行账户曾被冻结。截至本公告披露日，力诺制药被冻结的银行账户已全部解除冻结，恢复正常使用。账户冻结期间未对力诺制药的资金周转和日常生产经营活动造成实质性影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","161121","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786766402997,"stockEarnings":[{"period":"1week","weight":0.0546},{"period":"1month","weight":-0.1374},{"period":"3month","weight":0.1314},{"period":"6month","weight":0.1648},{"period":"1year","weight":0.2399},{"period":"ytd","weight":0.4912}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东科源制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8878人(较上一季度减少16.39%)","perCapita":"7991股","listingDate":"2023-04-04","address":"山东省济南市商河县山东商河经济开发区科源街","registeredCapital":"10829万元","survey":" 山东科源制药股份有限公司的主营业务是化学原料药及其制剂产品的研发、生产和销售。公司的主要产品是格列齐特、盐酸二甲双胍、盐酸罗哌卡因、单硝酸异山梨酯、单硝酸异山梨酯片、单硝酸异山梨酯缓释片、盐酸氟西汀分散片、化工中间体产品。","listedPrice":44.18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科源制药(301281)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科源制药(301281)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科源制药,301281,科源制药股票,科源制药股票老虎,科源制药股票老虎国际,科源制药行情,科源制药股票行情,科源制药股价,科源制药股市,科源制药股票价格,科源制药股票交易,科源制药股票购买,科源制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科源制药(301281)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科源制药(301281)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}